5 Startup Opportunities In Anti-Ageing [Forbes]
![Forbes](../../../Content/images/providers/Forbes.png)
Celularity Inc. - Class A (CELU)
Company Research
Source: Forbes
In this article, we explore five promising niches for innovative startups in the space. As more and more people around the world have access to better nutrition and healthcare, the global average life expectancy has been on a constant rise. According to , the worldwide life expectancy at birth (LEB) was measured at 73.3 years in 2019, compared to just above 50 years in 1965. In other words, nowadays the norm is that you won't die before you reach old age. Consequently, it's fair to argue that senescence is (or will soon become) the no. 1 health concern worldwide. So, products and services that promote longevity and higher quality of life are seeing ever-increasing demand. This process was boosted further by the rise in popularity of health tech, which was unsurprisingly one of the most consistent With advancements in science and technology (for example in ), there are numerous opportunities for startups to innovate in this space. In this article, we explore five promising oppo
Show less
Read more
Impact Snapshot
Event Time:
CELU
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CELU alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CELU alerts
High impacting Celularity Inc. - Class A news events
Weekly update
A roundup of the hottest topics
CELU
News
- Exosome Therapeutics Pipeline research 2024 [Yahoo! Finance]Yahoo! Finance
- Celularity Presents Data of The Effect of Its T-Cell Platform on Multiple Hematological And Solid Tumors at the American Society of Clinical Oncology (ASCO) Annual Meeting [Yahoo! Finance]Yahoo! Finance
- Celularity Presents Data of The Effect of Its T-Cell Platform on Multiple Hematological And Solid Tumors at the American Society of Clinical Oncology (ASCO) Annual MeetingGlobeNewswire
- Celularity announces receipt of Nasdaq notice regarding late Form 10-Q filing [Seeking Alpha]Seeking Alpha
- Celularity Inc. Announces Receipt of Nasdaq Notice Regarding Late Form 10-Q Filing [Yahoo! Finance]Yahoo! Finance
CELU
Earnings
- 1/2/24 - Miss
CELU
Sec Filings
- 5/24/24 - Form 8-K
- 5/21/24 - Form 8-K
- 5/15/24 - Form NT
- CELU's page on the SEC website